Product Information
ORIAHNN 300-1-0.5 MG/300 MG CAPS is a brand product labeled by AbbVie Inc., priced at $21.9862 per EA under NDC 00074101756. Its NADAC has been published 244 times since Sep 22, 2021.
FDA first approved this application on May 29, 2020.
Manufacturer
AbbVie Inc.NDC
00074101756
Classification
Brand
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA213388FDA Approved
5/29/2020
On Market Since
5/29/2020
Price Statistics
The NADAC for ORIAHNN 300-1-0.5 MG/300 MG CAPS has been published 244 times since Sep 22, 2021, and over the history we have for it it has risen 30.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.9862 per EA |
|---|---|
| All-time high | $21.9862 (Aug 19, 2026) |
| All-time low | $16.8370 (Sep 22, 2021) |
| 52-week high | $21.9862 |
| 52-week low | $20.7116 |
| Median price | $19.6502 |
| Average price | $19.5068 |
| Largest weekly change | +7.4% (Jan 26, 2022) |
| Weeks tracked | 244 |
| Tracking since | Sep 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Elagolix and Estradiol and Norethisterone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ORIAHNN 300-1-0.5 MG/300 MG CAPS?
The current National Average Drug Acquisition Cost (NADAC) for ORIAHNN 300-1-0.5 MG/300 MG CAPS, manufactured by AbbVie Inc., is $21.9862 per EA (NDC 00074101756), effective Aug 19, 2026.
How has the price of ORIAHNN 300-1-0.5 MG/300 MG CAPS changed over time?
Over the history we have for it, the NADAC for ORIAHNN 300-1-0.5 MG/300 MG CAPS has risen 30.6%. It has been tracked across 244 weekly CMS publications since Sep 22, 2021.
What are the highest and lowest recorded NADAC prices for ORIAHNN 300-1-0.5 MG/300 MG CAPS?
Since Sep 22, 2021, the NADAC for ORIAHNN 300-1-0.5 MG/300 MG CAPS has ranged from a low of $16.8370 (Sep 22, 2021) to a high of $21.9862 (Aug 19, 2026), with a median of $19.6502 per EA.
Are there cheaper alternatives to ORIAHNN 300-1-0.5 MG/300 MG CAPS?
No other NADAC-published product currently shares the active ingredient and strength of ORIAHNN 300-1-0.5 MG/300 MG CAPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ORIAHNN 300-1-0.5 MG/300 MG CAPS?
ORIAHNN 300-1-0.5 MG/300 MG CAPS (NDC 00074101756) is labeled by AbbVie Inc., and CMS classifies it as a brand product.